Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab add-on therapy for active systemic lupus erythematosus
ACTRN12607000327482Phase 3Recruiting
- Sponsor
- Kendle
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of belimumab in systemic lupus erythematosus (SLE) (3 arms), sponsored by Kendle. Started Jun 2007; status: recruiting.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ACTRN12607000327482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000327482.